RVPH Reviva Pharmaceuticals Holdings, Inc.
Healthcare$0.40-3.64%ClosedMarket Cap: $1.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.17
P/S
0.00
EV/EBITDA
1.24
DCF Value
$3.09
FCF Yield
-269953690.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-0.0%
ROA
-70.6%
ROIC
-95.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-3.3M | $-3.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.6M | $-3.4M | $— | — |
| FY null | $0.00 | NaN% | $-20.2M | $-19.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.0M | $-4.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.1M | $-6.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.5M | $-6.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.3M | $-6.3M | $— | — |
| FY null | $0.00 | NaN% | $-30.8M | $-29.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.5M | $-8.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.1M | $-7.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.9M | $-7.4M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-10.0M | $-9.7M | $-7.20 | — |